4.8 Article

Identification and Specification of the Mouse Skeletal Stem Cell

Journal

CELL
Volume 160, Issue 1-2, Pages 285-298

Publisher

CELL PRESS
DOI: 10.1016/j.cell.2014.12.002

Keywords

-

Funding

  1. National Institutes of Health (NIH) [U01HL099999, R01 CA86065, R01 HL058770, R01 DE021683, R21 DE024230, R01 DE019434, RC2 DE020771, U01 HL099776, R21 DE019274, 1R01CA158528, 1R01NS064517, 2U01DK085527-06]
  2. Siebel Fellowship from Thomas and Stacey Siebel Foundation
  3. Prostate Cancer Foundation Young Investigator Award
  4. Oak Foundation
  5. Hagey Laboratory for Pediatric Regenerative Medicine
  6. Gunn/Olivier Research Fund, StinehartReed Fund
  7. Stanford Medical Scientist Training Program [NIHT32GM007365]
  8. Stanford University Transplant and Tissue Engineering Center of Excellence Fellowship
  9. Plastic Surgery Foundation/Plastic Surgery Research Council
  10. American Society of Maxillofacial Surgeons Research
  11. Burroughs Wellcome Career Award for Medical Scientists [K08 DK096048 01]
  12. Stanford Developmental Cancer Research Award
  13. Stanford Medical Scientist Training Program, NIGMS [GM07365]
  14. Anonymous Donor Skeletal Stem Cell Research Fund
  15. [CIRM TR1- 01249]

Ask authors/readers for more resources

How are skeletal tissues derived from skeletal stem cells? Here, we map bone, cartilage, and stromal development from a population of highly pure, postnatal skeletal stem cells (mouse skeletal stem cells, mSSCs) to their downstream progenitors of bone, cartilage, and stromal tissue. We then investigated the transcriptome of the stem/progenitor cells for unique gene-expression patterns that would indicate potential regulators of mSSC lineage commitment. We demonstrate that mSSC niche factors can be potent inducers of osteogenesis, and several specific combinations of recombinant mSSC niche factors can activate mSSC genetic programs in situ, even in nonskeletal tissues, resulting in de novo formation of cartilage or bone and bone marrow stroma. Inducing mSSC formation with soluble factors and subsequently regulating the mSSC niche to specify its differentiation toward bone, cartilage, or stromal cells could represent a paradigm shift in the therapeutic regeneration of skeletal tissues.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available